公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2012 | Long-term results of a randomized, observation-controlled, phase III Trial of Adjuvant Interferon alfa-2b in hepatocellular carcinoma after curative resection | Chen L.-T.; Chen M.-F.; Li L.-A.; PO-HUANG LEE ; Jeng L.-B.; Lin D.-Y.; Wu C.-C.; Mok K.-T.; Chen C.-L.; Lee W.-C.; Chau G.-Y.; Chen Y.-S.; Lui W.-Y.; Hsiao C.-F.; Whang-Peng J.; PEI-JER CHEN | Annals of Surgery | 111 | 106 | |
2017 | Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naïve HIVpositive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in Taiwan | Wu P.-Y.; Cheng C.-Y.; Liu C.-E.; Lee Y.-C.; Yang C.-J.; Tsai M.-.S.; Cheng S.-H.; Lin S.-P.; Lin D.-Y.; Wang N.-C.; Lee Y.-.C.; HSIN-YUN SUN ; Tang H.-J.; CHIEN-CHING HUNG | PLoS ONE | 20 | 18 | |
2004 | Negative modulation of androgen receptor transcriptional activity by Daxx | Lin D.-Y.; Fang H.-I.; Ma A.-H.; Huang Y.-S.; YEONG-SHIAU PU ; Jenster G.; Kung H.-J.; Shih H.-M. | Molecular and Cellular Biology | 96 | 92 | |
2018 | A Phase I/Randomized Phase II Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Nintedanib versus Sorafenib in Asian Patients with Advanced Hepatocellular Carcinoma | Yen C.-J.; Kim T.-Y.; Feng Y.-H.; Chao Y.; Lin D.-Y.; Ryoo B.-Y.; Huang D.C.-L.; Schnell D.; Hocke J.; Loemb? A.-B.; ANN-LII CHENG | Liver Cancer | 19 | 22 | |
1997 | Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers | MING-WHEI YU ; Hsu F.-C.; Sheen I.-S.; Chu C.-M.; Lin D.-Y.; Chen C.-J.; Liaw Y.-F. | American Journal of Epidemiology | 267 | 234 | |
2013 | Sunitinib versus sorafenib in advanced hepatocellular cancer: Results of a randomized phase III trial | ANN-LII CHENG ; Kang Y.-K.; Lin D.-Y.; Park J.-W.; Kudo M.; Qin S.; Chung H.-C.; Song X.; Xu J.; Poggi G.; Omata M.; Lowenthal S.P.; Lanzalone S.; Yang L.; Lechuga M.J.; Raymond E. | Journal of Clinical Oncology | 619 | 599 |